SickKids launches trailblazing artificial intelligence program for paediatric health
On Mar. 27, 2025, The Hospital for Sick Children (SickKids) announced it is harnessing the transformative potential of…
On Mar. 27, 2025, The Hospital for Sick Children (SickKids) announced it is harnessing the transformative potential of…
On Mar. 27, 2025, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On Mar. 26, 2025, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the…
On Mar. 25, 2025, Merck announced it has signed a licensing agreement for a heart disease drug with…
On Mar. 25, 2025, GSK announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin)…
On Mar. 24, 2025, LifeScienceHistory.com published the cartoon “Milestones in Fluoride” illustrating the facts behind the naturally occurring…
On Mar. 24, 2025, Hideyuki Okano, a stem-cell scientist at Keio University in Tokyo, and his colleagues announced…
On Mar. 20, 2025, Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan, a major step towards finalizing a…
On Mar. 14, 2025, researchers from the Walter and Eliza Hall Institute of Medical Research (WEHI) announced they…
Mar. 13, 2025, Mallinckrodt and Endo,announced that they had entered into a definitive agreement to combine in a stock…
On Mar. 13, 2025, after two consecutive incubation periods (a total of 42 days) without a new confirmed…
On Mar. 11, 2025, researchers from Texas A&M University School of Public Health report findings show significant links…
On Mar. 11, 2025, researchers at St Vincent’s Hospital Sydney announced the first implant of a BiVACOR Total…
On Mar. 10, 2025, Beam Therapeutics announced initial safety and efficacy data from its Phase 1/2 trial of…
On Mar. 7, 2025, a team of researchers from Aalto University and the University of Bayreuth announced that…
On Mar. 6, 2025, Cornell researchers announced they have discovered a new mechanism that genes use to survive…
On Mar. 6, 2025, researchers at the University of Cambridge announced they have discovered genes linked to obesity…
On Mar. 4, 2025, researchers at a Mass Eye and Ear Institute-led trial announced taking stem cells from…
On Mar. 3, 2025, the Institute for Health Metrics and Evaluation reported that without urgent policy reform and…
On Mar. 3, 2025, researchers from Oregon State University (OSU) announced the world’s first procedure successfully fixes lamb’s…
On Mar. 3, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase),…
On Mar. 3, 2025, researchers at Fred Hutch Cancer Center announced they have discovered an overlooked mechanism driving…
On Feb. 27, 2025, ALK announced that the U.S. Food and Drug Administration (FDA) has approved ALK’s ODACTRA®…
In Feb. 26, 2025, Eli Lilly announced that it plans to bolster its domestic medicine production across therapeutic…
On Feb. 24, 2025, breast cancer is the most common cancer in women worldwide, but survival chances vary…
On Feb. 21, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has determined the…
On Feb. 21, 2025, a team of researchers from the Marine Biological Laboratory (MBL) announced a hybrid custom-designed…
On Feb. 20, 2025, researchers from the University of Washington and Seattle Children’s Research Institute announced findings from…
On Feb. 19, 2025, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Feb. 19, 2025, Alcon announced the full U.S. commercial availability of Voyagerâ„¢ DSLT, the first and only…